Literature DB >> 2938307

Effect of the variations of S-adenosyl-L-methionine liver content on fat accumulation and ethanol metabolism in ethanol-intoxicated rats.

F Feo, R Pascale, R Garcea, L Daino, L Pirisi, S Frassetto, M E Ruggiu, C Di Padova, G Stramentinoli.   

Abstract

The protective effect of S-adenosyl-L-methionine against rat liver steatosis induced by chronic ethanol ingestion was investigated. S-Adenosyl-L-methionine given during ethanol treatment prevented steatosis and accelerated recovery from steatosis when given after ethanol withdrawal. It also caused a slight inhibition of blood ethanol consumption in both acutely and chronically intoxicated rats. About 30% inhibition of alcohol dehydrogenase, but not of the microsomal ethanol oxidation system, occurred in rats subjected to acute ethanol toxicity as well as in normal rats as a consequence of S-adenosyl-L-methionine treatment. A comparison between S-adenosyl-L-methionine and pyrazole, as concerns inhibition of ethanol oxidation and fat accumulation, revealed that a greater inhibition of ethanol metabolism by pyrazole was associated with incomplete prevention of steatosis, while a lower inhibition by S-adenosyl-L-methionine was coupled to a complete prevention. Ethanol induced a drastic decrease of reduced glutathione liver content as well as 630 and 133% increases of blood and liver acetaldehyde contents, respectively. S-Adenosyl-L-methionine treatment almost completely reconstituted the liver reduced glutathione pool and caused a large decrease of the liver and blood acetaldehyde contents. 1-Chloro-2,4-dinitrobenzene, which depletes the cellular reduced glutathione, and diethylethanolamine, an inhibitor of the phosphatidylethanolamine methylation, abolished the S-adenosyl-L-methionine-induced modifications of the reduced glutathione, acetaldehyde, and triacylglycerol contents in the liver of ethanol-treated rats. Neither S-adenosyl-L-methionine nor reduced glutathione inhibitors affected the liver acetaldehyde dehydrogenase activity. It is suggested that, although S-adenosyl-L-methionine induced a small inhibition of ethanol metabolism in the liver, its antisteatosic effect could largely depend on its role as a modulator of the reduced glutathione liver content.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2938307     DOI: 10.1016/0041-008x(86)90310-8

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  17 in total

Review 1.  Mechanisms and consequences of the impaired trans-sulphuration pathway in liver disease: Part I. Biochemical implications.

Authors:  J M Mato; F Corrales; A Martin-Duce; P Ortiz; M A Pajares; C Cabrero
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 2.  Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease.

Authors:  R K Chawla; H L Bonkovsky; J T Galambos
Journal:  Drugs       Date:  1990       Impact factor: 9.546

3.  The role of SAMe in the treatment of liver disease.

Authors:  R Williams; C S Lieber
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 4.  Interaction of alcohol with other drugs and nutrients. Implication for the therapy of alcoholic liver disease.

Authors:  C S Lieber
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 5.  Hepatoprotective effects of S-adenosyl-L-methionine against alcohol- and cytochrome P450 2E1-induced liver injury.

Authors:  Arthur I Cederbaum
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

Review 6.  Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinoma.

Authors:  Rosa M Pascale; Claudio F Feo; Diego F Calvisi; Francesco Feo
Journal:  Transl Gastroenterol Hepatol       Date:  2018-06-29

7.  Effect of methotrexate on homocysteine and other sulfur compounds in tissues of rats fed a normal or a defined, choline-deficient diet.

Authors:  A M Svardal; P M Ueland; R K Berge; A Aarsland; N Aarsaether; P E Lønning; H Refsum
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 8.  Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis.

Authors:  Wing-Kin Syn; Vanessa Teaberry; Steve S Choi; Anna Mae Diehl
Journal:  Semin Liver Dis       Date:  2009-04-22       Impact factor: 6.115

9.  Mutational spectrum at GATA1 provides insights into mutagenesis and leukemogenesis in Down syndrome.

Authors:  Diane C Cabelof; Hiral V Patel; Qing Chen; Holly van Remmen; Larry H Matherly; Yubin Ge; Jeffrey W Taub
Journal:  Blood       Date:  2009-07-24       Impact factor: 22.113

10.  Protective and therapeutic effects of an extract mixture of alder tree, labiate herb, milk thistle green bean-rice bran fermentation, and turnip against ethanol-induced toxicity in the rat.

Authors:  Min-Won Baek; Seung-Hyeok Seok; Hui-Young Lee; Dong Jae Kim; Byoung-Hee Lee; Young-Tae Ahn; Kwang-Sei Lim; Chul-Sung Huh; Jae-Hak Park
Journal:  J Vet Sci       Date:  2008-03       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.